GC Biopharma Corp. 006280.KS Stock
GC Biopharma Corp. Price Chart
GC Biopharma Corp. 006280.KS Financial and Trading Overview
| GC Biopharma Corp. stock price | 111900 KRW |
| Previous Close | 116100 KRW |
| Open | 116700 KRW |
| Bid | 115000 KRW x 0 |
| Ask | 115100 KRW x 0 |
| Day's Range | 115000 - 117400 KRW |
| 52 Week Range | 113100 - 189500 KRW |
| Volume | 50.71K KRW |
| Avg. Volume | 34.56K KRW |
| Market Cap | 1.31T KRW |
| Beta (5Y Monthly) | 1.137671 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 KRW |
| Forward Dividend & Yield | 1750 (1.46%) |
| Ex-Dividend Date | December 28, 2022 |
| 1y Target Est | 158500 KRW |
006280.KS Valuation Measures
| Enterprise Value | 2.1T KRW |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | -2.59 |
| Price/Sales (ttm) | 0.79844046 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 1.279 |
| Enterprise Value/EBITDA | 22.678 |
Trading Information
GC Biopharma Corp. Stock Price History
| Beta (5Y Monthly) | 1.137671 |
| 52-Week Change | -26.98% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 189500 KRW |
| 52 Week Low | 113100 KRW |
| 50-Day Moving Average | 127030 KRW |
| 200-Day Moving Average | 128943 KRW |
006280.KS Share Statistics
| Avg. Volume (3 month) | 34.56K KRW |
| Avg. Daily Volume (10-Days) | 38.65K KRW |
| Shares Outstanding | 11.41M |
| Float | 5.45M |
| Short Ratio | N/A |
| % Held by Insiders | 51.46% |
| % Held by Institutions | 12.47% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | 83.00% |
| Payout Ratio | 0.5455 |
| Last Split Factor | 1.05:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 2.22% |
| Operating Margin (ttm) | 1.53% |
| Gross Margin | 32.48% |
| EBITDA Margin | 5.64% |
Management Effectiveness
| Return on Assets (ttm) | 0.62% |
| Return on Equity (ttm) | 1.92% |
Income Statement
| Revenue (ttm) | 1.64T KRW |
| Revenue Per Share (ttm) | 309593.7 KRW |
| Quarterly Revenue Growth (yoy) | -16.19% |
| Gross Profit (ttm) | N/A |
| EBITDA | 92.73B KRW |
| Net Income Avi to Common (ttm) | 36.61B KRW |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 95.45B KRW |
| Total Cash Per Share (mrq) | 8363.43 KRW |
| Total Debt (mrq) | 638.12B KRW |
| Total Debt/Equity (mrq) | 41.82 KRW |
| Current Ratio (mrq) | 1.636 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | 67.6B KRW |
| Levered Free Cash Flow (ttm) | -61469638656 KRW |
Profile of GC Biopharma Corp.
| Country | South Korea |
| State | N/A |
| City | Yongin-Si |
| Address | 107, Ihyeon-ro 30beon-gil |
| ZIP | N/A |
| Phone | 82 3 1260 9300 |
| Website | https://www.globalgreencross.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
GC Biopharma Corp., a biopharmaceutical company, develops drugs and vaccines in South Korea. The company provides plasma derivatives, including albumin, immunoglobulin, and antithrombin; and vaccines for hepatitis-B, Hantavirus hemorrhagic fever, influenza, flu, and varicella. It also offers prescription drugs for the bleeding symptom control and hemostasis for persons with hemophilia A; prevention and treatment of bleeding episodes induced by hemophilia A and post-operative treatment; and treatment of neutropenia, hunter syndrome, and liver cancer, as well as treatment of anti-inflammation, pain relief, and osteoarthritis. In addition, the company provides over the counter drugs. It also exports its products to approximately 50 countries. The company has a licensing and collaboration agreement with Tottori University for development of GM1 gangliosidosis chaperone therapy. GC Biopharma Corp. was founded in 1967 and is headquartered in Yongin-si, South Korea. GC Biopharma Corp. is a subsidiary of Green Cross Holdings Corporation.
Q&A For GC Biopharma Corp. Stock
What is a current 006280.KS stock price?
GC Biopharma Corp. 006280.KS stock price today per share is 111900 KRW.
How to purchase GC Biopharma Corp. stock?
You can buy 006280.KS shares on the KSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for GC Biopharma Corp.?
The stock symbol or ticker of GC Biopharma Corp. is 006280.KS.
Which industry does the GC Biopharma Corp. company belong to?
The GC Biopharma Corp. industry is Drug Manufacturers-Specialty & Generic.
How many shares does GC Biopharma Corp. have in circulation?
The max supply of GC Biopharma Corp. shares is 11.41M.
What is GC Biopharma Corp. Price to Earnings Ratio (PE Ratio)?
GC Biopharma Corp. PE Ratio is now.
What was GC Biopharma Corp. earnings per share over the trailing 12 months (TTM)?
GC Biopharma Corp. EPS is 0 KRW over the trailing 12 months.
Which sector does the GC Biopharma Corp. company belong to?
The GC Biopharma Corp. sector is Healthcare.